Cash

Trending Midterms Elections Politics Sports Culture Crypto Commodities Climate Economics Mentions Finance Tech & Science

Predict Live100 AccountSocial

MARKETS PERPS LIVE100

Product

Kalshi Pro Perpetual Futures Markets Incentive program Institutions API & developers

Company

About Kalshi Research Blog Careers Policy Center Brand Kit

Help

Help Center FAQ Fee schedule Trading hours Regulatory Trust Center

© 2026 Kalshi Inc. · All rights reserved

Privacy Data Terms of Service Trading Prohibitions FAQ for Finance Professionals

Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.

Johnson & Johnson (JNJ) earnings | Kalshi

Johnson & Johnson

JNJ

ReportsOct 13, 2026 · time not confirmed

Fiscal periodNot stated

Market cap$611.61B

Consensus EPS$2.53 · 6 estimates

Year-ago EPSNot available

Expected changeNot available

Quarterly markets

What will Johnson & Johnson say during their next earnings call?

Vaccine
100%
Administration
100%
Nipocalimab / Lupus
100%
Darzalex Faspro
100%
Ottava
100%
Litigation
100%
AI / Artificial Intelligence
100%
Halda Therapeutics
100%
China
100%
Rybrevant
100%
Tariff
100%
Procedure
100%

4 more words trade on this call